Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Psoriasis

Upadacitinib as monotherapy and in combination with non-biologic disease- modifying antirheumatic drugs for psoriatic arthritis

Rheumatology | Dec 14, 2021 Psoriasis

Phase 3 trials of tapinarof cream for plaque psoriasis

New England Journal of Medicine | Dec 13, 2021 Psoriasis

Evaluation of a case series of patients with generalized pustular psoriasis in the United States

JAMA Dermatology | Dec 12, 2021 Psoriasis

Immunohistochemical expression of cornulin in lesional and perilesional skin of plaque psoriasis

Journal of Cosmetic Dermatology | Dec 08, 2021 Psoriasis

Oligoarticular vs polyarticular psoriatic arthritis: A longitudinal study showing similar characteristics

The Journal of Rheumatology | Dec 07, 2021 Psoriasis

Relationship between iodine-enhanced dual energy-computed tomographic findings and ultrasonographic findings for psoriatic arthritis

The Journal of Dermatology | Dec 07, 2021 Psoriasis

Absolute Psoriasis Area and Severity Index as a valuable marker to determine initial treatment response in psoriasis patients treated with guselkumab in routine clinical care

Dermatologic Therapy | Dec 03, 2021 Psoriasis

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumor necrosis factor inhibitors: Results through one year of a phase IIIb, randomized, controlled study (COSMOS)

Annals of Rheumatic Diseases | Dec 01, 2021 Psoriasis

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomized, double-blind, phase 3 KEEPsAKE 2 trial

Annals of Rheumatic Diseases | Nov 26, 2021 Psoriasis

A brief screening tool for depression in psoriasis patients: The Two Questions Test in clinical practice

The Journal of Dermatology | Nov 25, 2021 Psoriasis

« Prev 1 2 3 4 5 … 49 Next »

Upadacitinib as monotherapy and in combination with non-biologic disease- modifying antirheumatic drugs for psoriatic arthritis

Phase 3 trials of tapinarof cream for plaque psoriasis

Evaluation of a case series of patients with generalized pustular psoriasis in the United States

Immunohistochemical expression of cornulin in lesional and perilesional skin of plaque psoriasis

Oligoarticular vs polyarticular psoriatic arthritis: A longitudinal study showing similar characteristics

Relationship between iodine-enhanced dual energy-computed tomographic findings and ultrasonographic findings for psoriatic arthritis

Absolute Psoriasis Area and Severity Index as a valuable marker to determine initial treatment response in psoriasis patients treated with guselkumab in routine clinical care

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumor necrosis factor inhibitors: Results through one year of a phase IIIb, randomized, controlled study (COSMOS)

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomized, double-blind, phase 3 KEEPsAKE 2 trial

A brief screening tool for depression in psoriasis patients: The Two Questions Test in clinical practice

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Top Foods to Combat Winter Illness

Pulmonary Embolism: MCQs Challenge

The Role of Nutrition in Enhancing Fertility for Men and Women

Upadacitinib as monotherapy and in combination with non-biologic disease- modifying antirheumatic drugs for psoriatic arthritis

Phase 3 trials of tapinarof cream for plaque psoriasis

Evaluation of a case series of patients with generalized pustular psoriasis in the United States

Immunohistochemical expression of cornulin in lesional and perilesional skin of plaque psoriasis

Oligoarticular vs polyarticular psoriatic arthritis: A longitudinal study showing similar characteristics

Relationship between iodine-enhanced dual energy-computed tomographic findings and ultrasonographic findings for psoriatic arthritis

Absolute Psoriasis Area and Severity Index as a valuable marker to determine initial treatment response in psoriasis patients treated with guselkumab in routine clinical care

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumor necrosis factor inhibitors: Results through one year of a phase IIIb, randomized, controlled study (COSMOS)

Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomized, double-blind, phase 3 KEEPsAKE 2 trial

A brief screening tool for depression in psoriasis patients: The Two Questions Test in clinical practice

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Top Foods to Combat Winter Illness

Pulmonary Embolism: MCQs Challenge

The Role of Nutrition in Enhancing Fertility for Men and Women

Select Specialty

Select Topic